Stoke Therapeutics, Inc. Share Price

Stoke Therapeutics, Inc. Share Price

NASDAQ: STOK | Small Cap
$26.27
-$0.08 (-0.3%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Stoke Therapeutics, Inc. Stock Performance

Open
$25.98
Prev. Close
$26.35
Circuit Range
N/A
Day Range
$25.98 - $26.64
Year Range
$20.33 - $40.19
Volume
83,755
Average Traded
$26.25

Stoke Therapeutics, Inc. Share Price Today

As of 1 November 2026, Stoke Therapeutics, Inc.'s share price is $26.27. The stock opened at $25.98, compared to its previous close of $26.35. During today's trading session, Stoke Therapeutics, Inc.'s share price traded between $25.98 and $26.64, with an average price of $26.31. Over the past 52 weeks, the stock has recorded a high of $40.19 and a low of $20.33. In terms of performance, Stoke Therapeutics, Inc.'s share price has declined by 19.66% over the last six months and is down 12.40% on a year-on-year basis.

Stoke Therapeutics, Inc. Share Price Chart

Line chart of the Stoke Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 25.91 to 26.69, ending at 26.27.
$25.98$26.64
L
Show Current Price
H

Stoke Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.56B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.22
Revenue (TTM)
$184.42B
Return On Equity (TTM)
-60.17%
Profit Margin
-3.74%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-60.68%

Stoke Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$10.63$1.40$6.23$9.33
Net Profit-$38.35-$57.93-$50.00-$61.62
Net Profit Margin-360.77%-4137.86%-802.57%-660.45%
Income ChangeN/A-51.06%13.69%-23.24%

Stoke Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$12.41$8.78$36.56$184.42
Net Profit-$101.07-$104.70-$88.98-$6.89
Net Profit Margin-814.42%-1192.48%-243.38%-3.74%
Income ChangeN/A-3.59%15.01%92.26%

About Stoke Therapeutics, Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Stoke Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$26.07
$26.31
+1.02%
Sep 2026
$30.72
$26.05
-20.19%
Aug 2026
$28.94
$32.63
+13.10%
Jul 2026
$33.26
$28.86
-11.83%
Jun 2026
$30.71
$32.73
+5.96%
May 2026
$33.14
$30.89
-5.55%
Apr 2026
$32.97
$32.70
+0.54%
Mar 2026
$36.06
$32.52
-10.77%
Feb 2026
$29.95
$36.45
+20.06%
Jan 2026
$31.43
$30.36
-4.26%
Dec 2025
$30.52
$31.71
+2.19%
Nov 2025
$29.25
$31.03
+3.47%

STOK Share Price FAQs